CD34+/Ph+ cells are still detectable in chronic myeloid leukemia patients with sustained and prolonged complete cytogenetic remission during treatment with imatinib mesylate.
作者信息
Bocchia M, Ippoliti M, Gozzetti A, Abruzzese E, Calabrese S, Amabile M, Pirrotta M T, Crupi R, Tozzuoli D, Trawinska M M, Defina M, Martinelli G, Lauria F
出版信息
Leukemia. 2008 Feb;22(2):426-8. doi: 10.1038/sj.leu.2404893. Epub 2007 Aug 9.
PMID:17690698
Abstract
摘要
Zotero 插件